Rochester, NY 8/21/2009 10:27:33 AM
Anika Therapeutics Inc. ANIK , North America Approval in Anika Single-Injection Osteoarthritis
Anika Therapeutics Inc.
Health Canada approval marks an important next step as we continue to expand the geographic reach of our novel osteoarthritis treatment therapy and establish MONOVISC as the premier single-injection product on the market worldwide, said Charles H. Sherwood, Ph.D., Anika’s President and Chief Executive Officer.
We are successfully moving forward on our goal of achieving FDA approval for MONOVISC in the U.S. The initial PMA modules have been submitted to the FDA and are currently under review. We expect to submit the final module containing the clinical study data prior to year-end 2009. We are confident that MONOVISC will be as well received in North America as it has been in Europe.
Anika Therapeutics, Inc. ANIK, a leader in products for tissue protection, healing and repair based on hyaluronic acid HA technology, today announced that it has received Health Canada approval for MONOVISC™, its single injection viscosupplement approved for the treatment of osteoarthritis of the knee. Anika expects to launch MONOVISC this month through its long-term ORTHOVISC® distribution partner in Canada, Rivex Pharma Inc., the specialty drug distribution division of Aurora, Ontario-based Helix BioPharma Corp.TSX: HBP - News. MONOVISC has been broadly available in the European Union since the second quarter of 2008.
About WhisperFromWallStreet
WhisperFromWallStreet.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified.
This is a free service available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://WhisperFromWallStreet.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither WhisperfromWallStreet, nor any of its affiliates are registered investment advisors or broker dealers.
